References
1. FDA Grants Accelerated Approval for Alzheimer's Drug Internet Document : 9 Jun 2021. Available from: URL: https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug
2. Mahase E. FDA approves controversial Alzheimer's drug despite uncertainty over effectiveness Internet Document : 9 Jun 2021. Available from: URL: https://www.bmj.com/content/373/bmj.n1462
3. Institute for Clinical and Economic Review. ICER Issues Statement on the FDA's Approval of Aducanumab for Alzheimer's Disease Internet Document : 9 Jun 2021. Available from: URL: https://icer.org/news-insights/press-releases/icer-issues-statement-on-the-fdas-approval-of-aducanumab-for-alzheimers-disease/
Rights and permissions
About this article
Cite this article
FDA grants accelerated approval to controversial Alzheimer's drug, aducanumab. PharmacoEcon Outcomes News 880, 36 (2021). https://doi.org/10.1007/s40274-021-7794-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7794-9